Ampio Pharmaceuticals. Inc.
15 clinical trials · Sponsor
◉ Watch Ampio Pharmaceuticals. Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen (NCT04839965) | Ampio Pharmaceuticals. Inc. | 2021-07-05 |
| A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 (NCT04868890) | Ampio Pharmaceuticals. Inc. | 2021-06-22 |
| Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress (NCT04606784) | Ampio Pharmaceuticals. Inc. | 2020-10-28 |
| Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation (NCT04456452) | Ampio Pharmaceuticals. Inc. | 2020-07-27 |
| Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee (NCT03349645) | Ampio Pharmaceuticals. Inc. | 2017-12-08 |
Track Ampio Pharmaceuticals. Inc. automatically
Every clearance here is in the API, with alerts when new ones post.